Results 11 to 20 of about 25,289 (109)

Heterologous prime-boost-boost immunisation of Chinese cynomolgus macaques using DNA and recombinant poxvirus vectors expressing HIV-1 virus-like particles [PDF]

open access: yes, 2011
Background: There is renewed interest in the development of poxvirus vector-based HIV vaccines due to the protective effect observed with repeated recombinant canarypox priming with gp120 boosting in the recent Thai placebo-controlled trial.
Anson, Donald S.   +9 more
core   +4 more sources

Vaccines for preventing enterotoxigenic Escherichia coli (ETEC) diarrhoea (Review) [PDF]

open access: yes, 2013
Background Infection with enterotoxigenic Escherichia coli (ETEC) bacteria is a common cause of diarrhoea in adults and children in developing countries and is a major cause of 'travellers' diarrhoea' in people visiting or returning from endemic regions.
Ahmed, Tanvir   +4 more
core   +1 more source

High Hepatitis E Seroprevalence Among Displaced Persons in South Sudan. [PDF]

open access: yes, 2017
Large protracted outbreaks of hepatitis E virus (HEV) have been documented in displaced populations in Africa over the past decade though data are limited outside these exceptional settings.
Azman, Andrew S   +12 more
core   +1 more source

Vaccine Policy in India [PDF]

open access: yes, 2005
India enjoyed early initial successes in vaccine development and indigenous production of vaccines in the public sector.
Bhargava   +8 more
core   +3 more sources

In Vitro Expression Of The Ctxb Toxin Gene Towards The Development Of A Dna Vaccine Against Cholera [PDF]

open access: yes, 2001
The complete eradication of cholera is an unachievable goal because it is now firmly established that there are environmental reservoirs for Vibrio cholerae.
Abdullah, Sharilnizam
core  

Mucosal delivery of tuberculosis vaccines: a review of current approaches and challenges. [PDF]

open access: yes, 2019
Introduction: Tuberculosis (TB) remains a major health threat and it is now clear that the current vaccine, BCG, is unable to arrest the global TB epidemic. A new vaccine is needed to either replace or boost BCG so that a better level of protection could
Barclay WR   +8 more
core   +1 more source

WHAT YOU SHOULD KNOW ABOUT HOG CHOLERA [PDF]

open access: yes, 1959
I. WHAT IS HOG CHOLERA? Hog cholera is a deadly, contagious disease that attacks swine only. The disease is caused by hog cholera virus, an agent so small (1/250,000 of an inch) that it can even pass through a fine porcelain filter.
Aitken, W.A.   +7 more
core   +1 more source

The African cholera surveillance network (Africhol) consortium meeting, 10–11 June 2015, Lomé, Togo [PDF]

open access: yes, 2017
The fifth annual meeting of the African cholera surveillance network (Africhol) took place on 10–11 June 2015 in Lomé, Togo. Together with international partners, representatives from the 11 member countries -Cameroon, Côte d’Ivoire, Democratic Republic ...
Abiba Banla Kere   +22 more
core   +1 more source

Recombinant expression systems: the obstacle to helminth vaccines? [PDF]

open access: yes, 2007
A
Claerebout, Edwin   +3 more
core   +2 more sources

Evaluation of the epidemiological importance of classical swine fever infected, E2 sub-unit marker vaccinated animals with RT-nPCR positive blood samples [PDF]

open access: yes, 2005
<p>It has been demonstrated that pigs that have been double vaccinated with an E2 sub-unit marker vaccine and that are infected with classical swine fever virus (CSFV) through a natural contact infection may react positive in a CSFV detecting RT ...
Dewulf, Jeroen   +5 more
core   +2 more sources

Home - About - Disclaimer - Privacy